Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall—a sub-analysis of the UTOPIA trial

[1]  T. Kanda,et al.  Effects of tofogliflozin on adrenocorticotropic hormone, renin and aldosterone, and cortisol levels in elderly patients with diabetes mellitus , 2021, Medicine.

[2]  I. Shimomura,et al.  Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes , 2021, Cardiovascular Diabetology.

[3]  I. Shimomura,et al.  Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study , 2020, Cardiovascular Diabetology.

[4]  J. Suri,et al.  Carotid Intraplaque-Hemorrhage Volume and Its Association with Cerebrovascular Events , 2019, American Journal of Neuroradiology.

[5]  André Rodrigues,et al.  Mellitus , 2018, Proceedings of the 17th International Conference on Mobile and Ubiquitous Multimedia.

[6]  H. Randeva,et al.  Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice , 2018, Cardiovascular Diabetology.

[7]  A. Gnasso,et al.  Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy , 2018, Cardiovascular Diabetology.

[8]  I. Shimomura,et al.  Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE) , 2018, Cardiovascular Diabetology.

[9]  R. Guthrie.  Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.

[10]  I. Shimomura,et al.  Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial , 2018, Diabetes Therapy.

[11]  Publisher's Note , 2018, Anaesthesia.

[12]  I. Shimomura,et al.  Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study , 2017, Diabetes Therapy.

[13]  P. Ambrosino,et al.  Markers of atherosclerosis in patients with Cushing’s syndrome: a meta-analysis of literature studies , 2017, Annals of medicine.

[14]  K. Park,et al.  The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE−/− mice fed a western diet , 2017, Diabetologia.

[15]  M. Fischereder,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.

[16]  Yu Hasegawa,et al.  Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice , 2014, Cardiovascular Diabetology.

[17]  I. Shimomura,et al.  The risk factors associated with ultrasonic tissue characterization of carotid plaque in type 2 diabetic patients. , 2014, Journal of diabetes and its complications.

[18]  G. Kaltsas,et al.  Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. , 2014, The Journal of clinical endocrinology and metabolism.

[19]  A. Majid,et al.  Symptomatic and asymptomatic carotid artery plaque , 2011, Expert review of cardiovascular therapy.

[20]  K. Kodama,et al.  Detection of disrupted plaques by coronary CT: comparison with angioscopy , 2011, Heart.

[21]  A. Nicolaides,et al.  The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins? , 2010, Atherosclerosis.

[22]  Nobuyuki Taniguchi,et al.  Standard method for ultrasound evaluation of carotid artery lesions , 2009, Journal of Medical Ultrasonics.

[23]  L. Lind,et al.  Echogenecity of the carotid intima-media complex is related to cardiovascular risk factors, dyslipidemia, oxidative stress and inflammation: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. , 2009, Atherosclerosis.

[24]  A. Comlekçi,et al.  Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma , 2009, Endocrine.

[25]  L. Saba,et al.  Fissured Fibrous Cap of Vulnerable Carotid Plaques and Symptomaticity: Are They Correlated? Preliminary Results by Using Multi-Detector-Row CT Angiography , 2009, Cerebrovascular Diseases.

[26]  M. Wintermark,et al.  High-Resolution CT Imaging of Carotid Artery Atherosclerotic Plaques , 2008, American Journal of Neuroradiology.

[27]  Masatoshi Ishibashi,et al.  The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. , 2007, European heart journal.

[28]  Yoshihiro Mukuta,et al.  Evaluation of a new carotid intima-media thickness measurement by B-mode ultrasonography using an innovative measurement software, intimascope. , 2006, American journal of hypertension.

[29]  Y. Yamasaki,et al.  Recent Advances of Intervention to Inhibit Progression of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes Mellitus , 2006, Stroke.

[30]  H. Kaneto,et al.  Lipid-lowering with atorvastatin improves tissue characteristics of carotid plaque. , 2005, Atherosclerosis.

[31]  O. Joakimsen,et al.  Low Levels of High-Density Lipoprotein Cholesterol Are Associated With Echolucent Carotid Artery Plaques: The Tromsø Study , 2001, Stroke.

[32]  Torben V. Schroeder,et al.  Ultrasonic Echolucent Carotid Plaques Predict Future Strokes , 2001, Circulation.

[33]  P. Shah,et al.  Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization , 2001, Circulation.

[34]  J M Stevens,et al.  Reproducibility of Computer-Quantified Carotid Plaque Echogenicity: Can We Overcome the Subjectivity? , 2000, Stroke.

[35]  C. Yuan,et al.  Visualization of Fibrous Cap Thickness and Rupture in Human Atherosclerotic Carotid Plaque In Vivo With High-Resolution Magnetic Resonance Imaging , 2000, Circulation.

[36]  M. Giannaki,et al.  Carotid Atherosclerosis in Adolescents and Young Adults With IDDM: Relation to urinary endothelin, albumin, free cortisol, and other factors , 1998, Diabetes Care.

[37]  T V Schroeder,et al.  Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[38]  N. Nishi,et al.  Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. , 1997, Stroke.

[39]  L. Chambless,et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.

[40]  J. Salonen,et al.  Determinants of carotid intima‐media thickness: a population‐based ultrasonography study in Eastern Finnish men , 1991, Journal of internal medicine.

[41]  B. Fagerberg,et al.  Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men. , 2007, Atherosclerosis.